Last reviewed: May 31, 2026 Last updated: May 31, 2026 Written by: Jay Hastings , CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations
By offering direct infusions, we ensure maximum absorption and high bioavailability, effectively promoting cellular vitality and rejuvenation, backed by Dr
Cosmetic variants are blended with excipients, preservatives, and multiple other ingredients, making them entirely unsuitable for controlled in vitro studies
The regulatory environment continues to evolve, and patients should stay informed about current availability through their prescribers and pharmacies
doi: 10.1097/00005537-200108000-00028